Endoscopic anti-reflux devices (with videos)

BACKGROUND GERD is one of the most common GI diseases, accounting for 7 million annual outpatient visits in the United States.1 Lifestyle modification and medical therapy, including acid-suppressive medications, are first-line treatments for GERD.2,3 In approximately 30% to 40% of patients with GERD, medical therapy provides only partial relief of symptoms.4 Laparoscopic anti-reflux surgery remains… Read more »

Laparoscopic Hiatal Hernia Repair and Transoral Incisionless Fundoplication with EsophyX Device Efficacy and Safety in Two Community Hospitals 99 Patients

Introduction GERD unresponsive to medical therapies can be treated by laparoscopic Nissen fundoplication or endoluminal techniques. We describe our experience using the TIF procedure with the EsophyX device. The TIF procedure is not indicated in patients with a hiatal hernia larger than 2 cm. Performing a hiatal hernia repair (HHR) in those cases will make… Read more »

Endoscopic fundoplication: patient selection and technique

Gastroesophageal reflux disease (GERD) is a common condition that places a significant burden on the healthcare system. Additionally, there have been concerns raised about potential risks of long-term proton pump inhibitors. Laparoscopic anti-reflux surgery is currently the gold standard option for patients when surgery is planned. However, there continues to be interest in an endoscopic,… Read more »

Endoscopic Fundoplication: Effectiveness for Controlling Symptoms of Gastroesophageal Reflux Disease

OBJECTIVE: Transoral incisionless fundoplication (TIF) is a completely endoscopic approach to treat gastroesophageal reflux disease (GERD). We previously reported our initial results demonstrating safety and early effectiveness. We now present an updated experience describing outcomes with longer follow-up. METHODS: For a three-year period, TIF procedures were performed on 80 patients. Preoperative workup routinely consisted of… Read more »

Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency

BACKGROUND & AIMS: Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) suppress gastric acid production, which can inhibit iron absorption. However, few data exist regarding whether these medications increase the risk of clinical iron deficiency. METHODS: A community-based case-control study evaluated the association between acid-suppressing medication use and the subsequent risk of iron deficiency.… Read more »

Long-term benefit of transoral incisionless fundoplication using the EsophyX device for the management of gastroesophageal reflux disease responsive to medical therapy

Transoral incisionless fundoplication (TIF) using the EsophyX device has been shown to be effective and safe in patients with Gastroesophageal reflux disease (GERD); however, the subset of patients that would mostly benefit from this technique remains unknown. The aim of this study was to evaluate the long-term efficacy and safety of the TIF procedure in… Read more »

Proton Pump Inhibitor Use Increases the Associated Risk of First-Time Ischemic Stroke. A Nationwide Cohort Study

Introduction: Use of proton pump inhibitors has been linked with endothelial dysfunction and increased risk of myocardial infarction. Hypothesis: We hypothesize that use of proton pump inhibitors (PPIs) increases the risk of ischemic stroke. Methods: Using nationwide Danish registries, we performed a retrospective cohort study. We identified all individuals above 30 years, who had an… Read more »